Latest Stock Market News

Five Nifty500 stocks closed over 2% above VWAP on May 5, indicating bullish momentum and strengthening market sentiment.

BlackRock s Ben Powell suggests rising US 10-year Treasury yields, driven by persistent US inflation and trade tensions, could dampen economic optimism. This limits the Federal Reserve s ability to cut rates, while investors demand higher compensation for long-term investment risk. Despite potential demand contraction, companies are investing in AI to boost productivity amid global uncertainty.

Mahindra & Mahindra s Q4 results exceeded expectations, with a 22% YoY increase in standalone net profit and a 24% rise in revenue. The company s strong performance was driven by double-digit growth across its auto and farm segments, leading to an increased dividend payout. Brokerages remain bullish, citing robust growth prospects and new product launches.

In an exclusive interview with ETMarkets, Lakhotia shares his ideal portfolio mix for this age group, highlighting a 50% allocation to equities, 20% to gold, 10% to REITs or international funds, and 20% to debt instruments.

From the tactical success of the Elever FactorShields Fund, which delivered 20% returns in FY25, to sharp views on the US-led macro shifts and sector rotation strategies, Aggarwal outlines how investors can align portfolios for stability and long-term alpha. Edited Excerpts –

Cyient Limited faces scrutiny as its American branch, Cyient Incorporated, receives a penalty. The Internal Revenue Service issued the order. It relates to alleged non-compliance with the Affordable Care Act. Cyient is challenging the decision. The company reported a profit jump in Q4. However, revenue saw a slight dip. Technical indicators for Cyient stock present a mixed outlook.

JM Financial maintains a buy call on Ambuja Cements with a target price of Rs 635, citing strong volume growth and better-than-expected realization. Ambuja s consolidated volume grew by 13% YoY and QoQ, with EBITDA increasing significantly QoQ. The company aims to expand capacity to 140mt by FY28, supported by a robust balance sheet and dominant market position.

Glenmark Pharma s innovation arm, IGI, received FDA fast track designation for its myeloma therapy ISB 2001, targeting heavily pre-treated RRMM patients. The tri-specific antibody showed high response rates and a favorable safety profile in early trials. Complete results will be presented at ASCO 2025. The stock rose 2.2% on Monday, with analysts maintaining a Buy rating.

The dollar rose in Asia on Tuesday fuelled by hopes for trade deals to avert Donald Trump s sweeping tariffs, while equities mostly rose as investors await the Federal Reserve s latest policy decision. Equities mostly rose, with Hong Kong and Shanghai leading the way as investors returned from a long weekend.

LIC strategically reshuffled its substantial equity portfolio in Q4, increasing investments in Reliance Industries, Tata Motors, and SBI. Conversely, the insurer reduced its holdings in ICICI Bank and IT giants like Infosys and TCS. This rebalancing reflects valuation adjustments, sectoral rotations, and portfolio management strategies in anticipation of FY26.s